The Securities and Exchange Commission is charging two Southern California doctors with insider trading on shares of a biopharmaceutical company after learning trials of a drug they were testing for the firm were halted by regulators.
Read More... [Source: MarketWatch.com - All MarketWatch News - CHU]
No comments:
Post a Comment